Current approaches to the psyckopharrnacologic treatment of depression in children and adolescents

Journal of Child and Adolescent Psychiatric Nursing

Volumn 9, Issue 1, 1996, Pages 15-26

  Laraia, Michele T ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Antidepressants; Depression; Psychobiology; Psychopharmacology

Indexed keywords

ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; CHILD; DEPRESSION; HUMAN; NURSING; PRACTICE GUIDELINE; PSYCHIATRIC NURSING; PSYCHOPHARMACOLOGY; REVIEW;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CHILD; DEPRESSIVE DISORDER; HUMANS; PRACTICE GUIDELINES; PSYCHIATRIC NURSING; PSYCHOPHARMACOLOGY;

EID: 0029694512     PISSN: 10736077     EISSN: 17446171     Source Type: Journal    
DOI: 10.1111/j.1744-6171.1996.tb00249.x     Document Type: Article

References (46)

1. Ambrosini, P. J., Bianchi, M. D., Rabinovich, H., & Elia, J. (1993). Antidepressant treatments in children and adolescents: I. Affective disorders, journal of the American Academy of Child and Adolescent Psychiatry, 32,1-6.
2. Angold, A., & Worthman, C. W. (1993). Puberty onset of gender differences in rates of depression: A developmental, epidemiologic and neuroendocrine perspective. Journal of Affective Disorders 29, 145-158.
3. American Psychiatric Association. (1994). Diagnostic and statistical manual (4th ed.). Washington, DC: Author.
4. Apter, A., Ratzoni, G., King, R. A., Weizman, A., Iancu, J., Binder, M., & Riddle, M.A. (1994). Fluvoxamine open-label treatment of adolescent inpatients with obsessive-compulsive disorder or depression. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 42-348.
5. Barrickman, I. (1995). Buproprion versus methylphenidate in the treatment of attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 34,649-657.
6. Biederman,J., & Steingard, R. (1991). Pediatric psychopharmacology. In A. J. Gelenberg, E. L. Bassuk, & S. C. Schoonover (Eds.), The practitioner's guide to psychoactive drugs (pp. 341 - 388), New York: Plenum.
7. Burke, P., & Puig-Antich, J. (1990). Psychobiology of childhood depression. In M. Lewis & S. M. Miller (Eds.), Handbook of developmental psychopathology (pp. 327-339). New York: Plenum Press.
8. Charmers, T. C, Smith, H., Blackburn, B., Silverman, B., Schroeder, B., Reitman, D., & Ambroz, A. (1981). A method for assessing the quality of a randomized controlled trial. Controlled Clinical Trials, 2,31 -39.
9. Clay, T. H., Gualtiere, C. T., Evans, R. W., & Gullion, C. M. (1988). Clinical and neuropsychological effects of the novel antidepressant buproprion. Psychoplxarmacology Bulletin, 24,143-148.
10. Depression Guideline Panel. (1993). Depression in primary care: Volume 1, detection and diagnosis. Clinical practice guideline, Number 5 (Publication No. 93-0550). Rockville, MD: U.S. Dept of Health and Human Services.
11. Devane, C. L, & Sallee, F. R. (In press). Selective serotonin reuptake inhibitors in child and adolescent psychopharmacology: A review of published experience. Journal of Clinical Psychiatnj.
12. Feinberg, I. (1991). Synaptic pruning and the adolescent brain. The Journal of the California Alliance for the Mentally III, 2(4), 22-24.
13. Fleming, J. E., & Offord, D. R. (1990). Epidemiology of childhood depressive disorders: A critical review. Journal of the American Academy of Child and Adolescent Psychiatry, 29,571 -580.
14. Geller, B., Fox, L. W., & Fletcher, M. (1994). Effect of tricyclic antidepres-sants on switching to mania and on the onset of bipolarity in depressed 6- to 12-year-olds with major depressive disorder, journal of the American Academy of Child and Adolescent Psychiatry, 32,43 - 50.
15. Gershon, E. S. (1990). Genetics. In F. K. Goodwin & K. R. Jamison (Eds.), Manic-depressive illness (pp. 448-461). New York: Oxford University Press.
16. Harrington, R., Fudge, H., Rutter, M., Pickles, A., & Hill, J. (1990). Adult outcomes of childhood and adolescent depression, I. Psychiatric status. Archives of General Psychiatry, 47,465-473.
17. Hazell, P., O'Connell, D., Heathcote, D., Robertson, J., & Henry, D. (1995). Efficacy of TCAs in treating child and adolescent depression: A meta-analysis. British Medical Journal, 310,897-901.
18. Joshi, P. T, Walkup, J. T., Capozzoli, J. A., Detrinis, R. B., & Coyle, J. T. (1989, October). Tlie use of fluoxetine in the treatment of major depressive disorder in children and adolescents. Paper presented at the 36th Annual Meeting of the American Academy of Child and Adolescent Psychiatry, New York.
19. Just the fax. (1995). Newsletter of the University of Wisconsin Child Psycho-pharmacology Information Center, 2(2), 1-4.
20. Keltner, N. L., & Folks, D. G. (1993). Psychotropic drugs. St. Louis: Mosby-Yearbook.
21. Killeen, M. R., & Bongarten, C. F. (1996). Caring for depressed children and adolescents. In A. B. McBride & J. K. Austin (Eds.), Psychiatrk-mental health nursing: Integrating the behavioral and biological sciences (pp. 189-234). Philadelphia: Saunders.
22. Kessler, R. C, McGonagle, K. A., Zhao, S., Nelson, C. B., Hughes, M., Eschleman, S., Wittchen, H., & Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: Results from the national comorbidity survey. Archnvs of General Psychiatry, 51, 8-19.
23. Kovacs, M., Feinberg, T. L, & Crouse-Novak, M. A. (1984). Depressive disorders in childhood. I. A longitudinal prospective study of characteristics and recovery. Archives of General Psychiatry, 41, 229-237.
24. Laraia, M. T. (1995). Psychopharmacology. In G. W. Stuart & S. J. Sundeen (Eds.), Principles and practice of psychiatric nursing (pp. 663 - 701). St. Louis. Mosbv-Yearbook.
25. McConville, B. J., Minnerv, K. L, Sorter, M. T., West, S. A., Christian, K., & Friedman, L. M. (1994, October). Sertralmc treatment of adolescent depression: An open exploratory/ study. Poster presented at the Meeting of the American Academy of Child and Adolescent Psychiatry, New York.
26. National Institute of Mental Health. (1992). Depression awareness, recognition, treatment fact sheet (Publication NO. (A) 92-1680 DHHS). Rockville, MD: Author.
27. Nurcombe, B., (1991) Malpractice. In M. Lewis (Ed.), Tlw comprehensive textbook of child psychiatry (pp. 1127-1139). Baltimore: Williams & Wilkins.
28. Pine, D. S., Trautman, P. D., Shatter, D., Cohen, L., Danes, M., Stanley, M., & Parsons, B. (1995). Seasonal rhythm of platelet [3Hlimipramine binding in adolescents who attempted suicide. American Journal of Psychiatry, 152, 923-925.
29. Popper, C. W. (1994). Child and adolescent psychopharmacology update: October 1992-December 1993. journal of Child and Adolescent Psychophannacologv, 4(1), 9 - 29.
30. Preskorn, S. H., Weller, E. B., & Hughes, C. W. (1987). Depression in prepubertal children: Dexamethasone non-suppression predicts differential response to imipramine vs. placebo. Psychopharmacolog Bulletin. 2.3, 128-133.
31. Preskorn, S. H., Bupp, S. J., Weller, E. B., & Weller, R. A. (1989). Plasma levels of imipramine and metabolites in 68 hospitalized children. journal of the American Academy of Child and Adolescent Psychiatry, 28, 373-375.
32. Puig-Antich, J., Perel, J. VI., & Lupatkin, W. (1989). Imipramine in prepubertal major depressive disorders. Archives of General Psychiatry, 44,81-89.
33. Puig-Anrich, J., Goetz, D., & Davies, M. (1989). A controlled family history study of prepubertal major depressive disorders. Archives of General Psychiatry. 46. 406-418.
34. Regier, D. A., Hirschfeld, R. M, & Goodwin, F. K. (1988). The NIMH depression awareness, recognition, and treatment program: Structure, aims, and scientific basis. American journal of Psychiatry, 245.1351-1337.
35. Riddle, M. A., Hardin, M. T., King, R., Scahill, L., & Woolston, J. L. (1990). Fluoxetine treatment of children and adolescents with Tourette's and obsessive compulsive disorders: Preliminary clinical experience. Journal of the American Academy of Child and Adolescent Psychiatry, 29,45- 48.
36. Riddle, M. A., Scahill, L., King, R. A., Hardin, M. T., Anderson, G. VI., Ort, S. I., Smith, C, Lechman, J. F, & Cohen, D. J. (1993). Double-blind, crossover trial of fluoxetine and placebo in children and adolescents with obsessive-compulsive disorder. Journal of the American Academy of Child and Adolescent Psychiatry, 37,1062-1069.
37. Rosenthal, N. E, Carpenter, B. S., James, S. P., Parry, B. L., Rogers, S. L. B., & Wher, T. A. (1986). Seasonal affective disorder in children and adolescents. American Journal of Psychiatry, 143,356-358.
38. Ryan, N. D., Puig-Antich, J., & Cooper, T. (1986). Imipramine in adolescent major depression: Plasma level and clinical response. Ada Psychiatric Scandanavia, 73,275-288.
39. Ryan, N. D., Meyer, V, Dachill, S., Mazzie, D., & Puig-Antich, J. (1988). Lithium anridepressant augmentation in TCA-refractory depression in adolescents. Journal of the Academy of Child and Adolescent Psychiatry, 17, 371-376.
40. Ryan, N. D., Puig-Antich, J., & Rabinovich, H. (1988). MAOIs in adolescent major depression unresponsive to TCA. Journal of the American Academy of Child and Adolescent Psychiatry, 27, 755-758.
41. Scahill, L. (1996). Contemporary approaches to pharmacotherapy in Tourette's syndrome and obsessive-compulsive disorder, journal of Child and Adolescent Psychiatric Nursing, 9(1), 27-43.
42. Scahill, L. & Lynch, K. A. (1994). Tricyclic antidepressants: Cardiac effects and clinical implications, journal of Child and Adolescent Psychiatric Nursing, 7(2), 37-39.
43. Stein, M. A., Szumowski, E., Ravitz, A. J., Frey, M. J., & Leventhal, B. L. (1994). Dexamethasone suppression and childhood depression: Association with categorical and dimensional measures, journal of Child and Adolescent Psychopliarmacolog, 4,43-52.
44. Steingard, R. (1995). Current perspectives on the pharmacotherapy of depressive disorders in children and adolescents. Harvard Revkiv of Psychiatry, 2,313-326.
45. Weller, E. B., Weller, R. A., & Fristad, M. A. (1986). Lithium dosage for prepubertal children: A preliminary report, journal of the American Academy of Child and Adolescent Psychiatry, 25,92-95.
46. Zametkin, A., Rapoport, J. L., Murphy, D. L., Linnoila, M., & Ismond, D. (1985). Treatment of hyperactive children with MAOIs: I. Clinical efficacy. Archives of General Psychiatry, 42,962-966.